𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Are functional erythropoietin receptors present in cancer cells?


Book ID
120847221
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2007
Weight
154 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


GRP receptors are present in non small c
✍ Dr. T. W. Moody; F. Zia; R. Venugopal; M. Fagarasan; H. Oie; V. Hu πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 871 KB

Previously, GRP receptors were characterized in small cell lung cancer cells and here non-small cell lung cancer (NSCLC) cells were investigated: (1251-Tyr4) bombesin (BN) or lZ51-GRP bound with high affinity to NCLH720 (lung carcinoid) and NCI-HI 299 (large cell carcinoma) cells. Binding was specif

Lack of functional erythropoietin recept
✍ Magdalena Laugsch; Eric Metzen; Tanja Svensson; Reinhard Depping; Wolfgang Jelkm πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 883 KB

## Abstract Erythropoietin (Epo) therapy reduces red cell transfusion requirements and improves the quality of life of anemic cancer patients receiving chemotherapy. However, there is concern that Epo may promote tumor growth. We investigated by real‐time RT‐PCR, immunofluorescence microscopy, West

Characterization of erythropoietin recep
✍ Jee-Yeong Jeong; Laurie Feldman; Peter Solar; Jolanta Szenajch; Arthur J. Sytkow πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 501 KB

## Abstract The identification of erythropoietin receptors (EpoR) on cancer cells has caused concern, since it implies the possibility that treatment of cancer patients with erythropoietin (Epo) and related agents with demonstrable antiapoptotic activity could enhance cancer growth and progression.